{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-095325","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2023-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.520173+00:00","generated_at":"2026-06-11T03:31:43.485616+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"First Wave BioPharma gets Nasdaq notice for bid price below $1 for 30 days","bullets":["Nasdaq notified First Wave BioPharma on Aug. 24, 2023 of non-compliance with Listing Rule 5550(a)(2).","Company has 180 days, until Feb. 20, 2024, to regain compliance by closing at $1.00 for 10+ consecutive days.","No immediate effect on listing; company may qualify for a second 180-day period if it meets other listing standards.","Failure to cure could lead to delisting, subject to appeal to a Nasdaq hearings panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-095325","json":"https://secwatch.observer/filing/0001104659-23-095325.json","markdown":"https://secwatch.observer/filing/0001104659-23-095325.md","text":"https://secwatch.observer/filing/0001104659-23-095325.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/0001104659-23-095325-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/tm2324766d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T03:31:43.485616+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f03ded757ad4282579359c67e8376509fcbc16be","claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"August 24, 2023, First Wave BioPharma, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Notice”). The Notice has no immediate effect on the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/0001104659-23-095325-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}